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ABSTRACT.
Glaucoma is one of the leading causes of blindness worldwide. Historically, it has
been considered an ocular disease primary caused by pathological intraocular
pressure (IOP). Recently, researchers have emphasized intracranial pressure
(ICP), as translaminar counter pressure against IOP may play a role in
glaucoma development and progression. It remains controversial what is the best
way to measure ICP in glaucoma. Currently, the ‘gold standard’ for ICP
measurement is invasive measurement of the pressure in the cerebrospinal fluid
via lumbar puncture or via implantation of the pressure sensor into the brains
ventricle. However, the direct measurements of ICP are not without risk due to
its invasiveness and potential risk of intracranial haemorrhage and infection.
Therefore, invasive ICP measurements are prohibitive due to safety needs,
especially in glaucoma patients. Several approaches have been proposed to
estimate ICP non-invasively, including transcranial Doppler ultrasonography,
tympanic membrane displacement, ophthalmodynamometry, measurement of
optic nerve sheath diameter and two-depth transcranial Doppler technology.
Special emphasis is put on the two-depth transcranial Doppler technology, which
uses an ophthalmic artery as a natural ICP sensor. It is the only method which
accurately and precisely measures absolute ICP values and may provide valuable
information in glaucoma.
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Introduction
Glaucoma is one of the leading causes
of blindness worldwide (Quigley &
Broman 2006) that continues to amass
evidence of its multifactorial nature.
Intraocular pressure (IOP) has been
regarded as one of the main risk factors
in the prevalence, incidence and pro-
gression of glaucoma (Leske et al.
2003). However, in many cases, glau-
coma continues to progress, despite
maintaining target IOP (Heijl et al.
2002; Leske et al. 2007). Obviously,
there are non-IOP factors involved in
the pathogenesis of primary open-angle
glaucoma (POAG) that can impact the
apoptotic process (Flammer et al.
1999). These include low systolic
ocular perfusion pressure, a reduction
of ocular blood ﬂow, low systolic
blood pressure, cardiovascular disease,
migraine, smoking and vasospastic dis-
orders (Bonomi et al. 2000; Hayreh
2001; Leske et al. 2008; Cherecheanu
et al. 2012). Recently, researchers have
emphasized intracranial pressure
(ICP), as translaminar counter pressure
against the IOP, role in glaucoma
(Jonas 2011; Ren et al. 2011).
Intraocular and ICPs are interre-
lated and relatively independent pres-
sure systems, which keeps themselves in
a relatively stable state through aque-
ous and cerebrospinal ﬂuid (CSF) cir-
culations. These two circulating ﬂuids
have many similarities as they both are
produced by carbonic anhydrase-catal-
ysed reactions, generally represent an
ultraﬁltrate of blood and have nearly
identical chemical composition, with
more proteins and less ascorbates in
CSF. Normal ICP varies with age
but is generally considered to be
5–15 mmHg in healthy supine adults,
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3–7 mmHg in children and1.5–6 mmHg
in infants (Albeck et al. 1991; Smith
2008). Physiologically, IOP and ICP
are dynamic parameters, both have
circadian variations (24-hr) and similar
response to changes in posture, intra-
abdominal or intrathoracic pressures
(Dickerman et al. 1999). IOP circadian
cycle is quite well known (Sit & Liu
2009); however, circadian pattern of
ICP is less clear, suggesting a nocturnal
elevation in ICP (Morrow et al. 1990;
Maurel et al. 1996). Zhang et al. found
that the Valsalva manoeuver-associ-
ated short-term increase in CSF pres-
sure was signiﬁcantly higher than
increase in IOP. It led to a Valsalva
manoeuver-associated decrease or
reversal of the translaminar cribrosa
pressure diﬀerence, which was associ-
ated with decreased optic cup-related
parameters and enlarged neuroretinal
rim-related parameters (Zhang et al.
2013). Other studies suggested that the
risk of glaucoma is higher in patients
with frequent Valsalva eﬀorts (Schu-
man et al. 2000; Krist et al. 2001).
Wostyn et al. (2011) hypothesized that
ﬂuctuations in ICP could result in
translaminar cribrosa pressure diﬀer-
ence ﬂuctuations and thus ﬂuctuations
in the shear stress in the retinal gan-
glion cell axons, ultimately leading to
glaucomatous damage. The role of ICP
in glaucoma still remains unconﬁrmed,
because only invasive ICP measure-
ments are widely available within the
contemporary medicine.
Currently, direct measurement of
CSF pressure via lumbar puncture or
via implantation of the pressure sensor
into the brains ventricle is considered to
be the ‘gold standard’ of ICP measure-
ment (Digre & Corbett 2001; Lenfeldt
et al. 2007; Andrews et al. 2008). CSF
pressure obtained via lumbar puncture
is normally determined by ICP; there-
fore, we use the term ICP and CSF
pressure interchangeably, as it is carried
out in clinical practice (Lenfeldt et al.
2007). However, the direct measure-
ments of ICP are not without risk due
to its invasiveness and potential risk of
intracranial haemorrhage, infection or
even cerebral herniation and hence can-
not be widely used as a matter of safety
concerns (Zeng & Gao 2010). More-
over, invasive methods lend themselves
only to a small portion of pathological
disorders in which ICP measurement
can be used, and consequently, many
patients who might beneﬁt from ICP
measurement, including glaucoma
patients, do not do so. Therefore, devel-
opment of non-invasive absolute ICP
measurement method could be a tool to
overcome the high risk to beneﬁt ratio of
current invasive ICP measurement
methods. In this article, we present a
novel non-invasive absolute ICP mea-
surement method using two-depth
transcranial Doppler device, which is
currently the only available method for
absolute ICP value numerical and auto-
matic measurement that does not need
an individual patient-speciﬁc calibra-
tion (Ragauskas et al. 2005, 2012).
Importance of
Intracranial Pressure in
Glaucoma
Contemplations of ICP role in glau-
coma started more than three decades
ago. Optic nerve head (ONH) is
located at the junction between the
relatively high-pressure intraocular
space and low-pressure subarachnoid
space (SAS); therefore, pressure imbal-
ance between these two regions may be
the cause of damage of retinal ganglion
cell axons that cross the lamina crib-
rosa (Volkov 1976; Morgan et al. 2002;
Burgoyne et al. 2005). The diﬀerence in
pressure that occurs across the lamina
cribrosa (IOP–ICP) is known as the
translaminar pressure gradient (TPG)
(Morgan et al. 1998). Physiologically,
the average IOP is slightly higher than
the average ICP, resulting in a small
posteriorly directed TPG diﬀerence
(mean 4 mmHg) (Gilland 1969). Nor-
mal IOP combined with low ICP pro-
duce the same pressure diﬀerential
across the lamina cribrosa as elevated
IOP in conjunction with normal ICP
(Greenﬁeld et al. 1997). Indeed, TPG is
not only aﬀected by IOP and ICP, but
also by the thickness of the lamina
cribrosa. Jonas et al. reported that lam-
ina cribrosa is thinner in myopes and
that there are morphometric changes in
lamina cribrosa in glaucomatous eyes,
including thinning (Jonas et al. 2003,
2004). The thinner lamina cribrosa
determines a higher TPG and creates a
steeper path that retrograde axonal
transport must traverse. Interestingly,
experimental studies revealed that lam-
ina cribrosa thickens at the earliest stage
of glaucoma (Yang et al. 2007).
Changes in TPG may lead to abnor-
mal function and optic nerve damage
due to changes in axonal transportation,
deformation of the lamina cribrosa,
altered blood ﬂow or a combination of
it. Experimental studies showed that
chronic reduction in CSF was associated
with the development of an optic neu-
ropathy in some monkeys (Yang et al.
2014). Other researchers showed that
ICP could pathogenetically be associ-
ated with structural changes in the ONH
similar to glaucomatous damage (Vol-
kov 1976; Morgan et al. 2002; Burgoyne
et al. 2005). Later Berdahl et al. in
retrospective analysis of patients who
had lumbar puncture revealed that ICP
was 3 to 4 mmHg lower in POAG
(Berdahl et al. 2008a), and its subset
normal-tension glaucoma (NTG), com-
pared with age-matched control subjects
and patients with ocular hypertension
(OH) (Berdahl et al. 2008b). Further,
they reported that the amount of glau-
comatous damage to the optic nerve
correlated with the TPG (Berdahl et al.
2008b). Recently, Ren et al. (2010) in a
prospective study found similar results
to those in the retrospective studies,
with the control group having the high-
est CSF pressure and the smallest TPG.
However, all these studies do not
represent long-term pressure varia-
tions, because only instantaneous mea-
surements of IOP and invasive ICP
were taken. It is still impossible to
assess how diﬀerences in ICP over time
may aﬀect the development or progres-
sion of POAG using a single-pressure
measurement. Moreover, assessment of
ICP ﬂuctuation, day–night variations
and their inﬂuence in glaucoma would
be very useful but limited due to
invasive ICP measurement procedures.
Non-Invasive ICP
Measurement
Approaches
Diﬀerent approaches for evaluating
physiological characteristics of ICP-
related cerebrospinal system have been
attempted by various authors (Firsching
et al. 2000; Bellner et al. 2004; Bauerle
& Nedelmann 2011; Li et al. 2012;
Ragauskas et al. 2012; Xie et al. 2013).
Transcranial Doppler ultrasonogra-
phy (TCD) is a simple non-invasive
method used to measure blood ﬂow
velocity in the middle cerebral artery
(MCA). The use of TCD as a predic-
tor of ICP was ﬁrst described byKlinge-
rhofer et al. They reported that changes
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of the ICP recordings inﬂuenced the
ﬂow patterns in TCD (Klingerhofer
et al. 1997). Several studies found that
MCA pulsatility index (PI), which is
calculated as diﬀerence between systolic
and diastolic ﬂow velocities, divided by
the mean ﬂow velocity, correlates with
ICP; however, correlation range was
from0.439 to 0.938 (Moreno et al. 2000;
Bellner et al. 2004; Voulgaris et al.
2005). In contrast, other researchers
failed to ﬁnd a relationship between PI
and ICP (Figaji et al. 2009; Behrens
et al. 2010; Brandi et al. 2010). Behrens
et al. (2010) announced that an ICP of
20 mmHg found using PI had 95%
conﬁdence intervals of 3.8 to
43.8 mmHg. It must be known that PI
depends on several factors such as arte-
rial pressure pulsatility, heart rate, cere-
bral perfusion pressure, arterial carbon
dioxide concentration, cerebral resis-
tance and compliance of the big vessels
(Czonsnyka 2001). Furthermore, there
are intra- and interobserver variations
(McMahon et al. 2007), and the tech-
nique cannot be used on 10–15% of
patients due to the ultrasound not being
able to penetrate the skull (Tsivgoulis
et al. 2009).
Ophthalmodynamometry (ODM) is
a useful method for measuring the
venous outﬂow pressure of the central
retinal vein (CRV) (Firsching et al.
2000). Physiologically, the pressure in
the CRV is equal to or higher than
ICP. After leaving the eye through the
optic disc, the CRV goes through the
retrobulbar part of the optic nerve
before it traverses the SAS and sub-
dural spaces of the optic nerve and
pierces the optic nerve meninges. The
technique involves applying slight pres-
sure to the orbital sclera using a cali-
brated force transducer to manipulate
intraocular tension. Tonometry and
ophthalmoscopy are additionally emp-
loyed to measure resting IOP and
visualize the instantaneous moment of
vein collapse. The pressure value at the
point of collapse is termed the venous
outﬂow and is found to linearly predict
ICP (Motschmann et al. 2001; Quer-
furth et al. 2010; Firsching et al. 2011).
Firsching et al. (2011) found that an
increased pressure of the CRV indi-
cated an elevated ICP, with a proba-
bility of 84.2%, whereas a normal
pressure of the CRV indicated a
normal ICP in 92.8% of patients.
Querfurth et al. (2010) showed that
ODM is able (area under curve 0.89;
95% CI 0.73–1.05) to predict raised
ICP. However, ODM cannot be
applied in cases of ocular trauma or
conditions that selectively aﬀect the
optic nerve and give erroneously high
readings in the presence of a papille-
dema, which may persist long after ICP
has returned to normal.
Tympanic membrane displacement
(TMD) technique requires a patent
cochlear aqueduct, normal middle ear
pressure and an intact stapedial reﬂex.
Stimulation of the stapedial reﬂex
causes a movement of the tympanic
membrane, which is shown to correlate
with ICP (Reid et al. 1990; Lang et al.
2003). Shimbles et al. found a correla-
tion between the invasively and TMD
measured ICP values. However, inter-
subject variability was so great that the
predictive limits of the regression
analysis were an order of magnitude
greater than normal ICP range, thus
precluding the method for clinical use
(Shimbles et al. 2005). Moreover, peri-
lymphatic duct is less passable with
age; thus, tympanic membrane dis-
placement measurements have a rela-
tively low practicability.
Recently, research has extended into
ultrasography of optic nerve sheath
diameter (ONSD) and its relation with
elevated ICP (Geeraerts et al. 2007).
Several researchers found correlations
between ICP and ONSD (Soldatos
et al. 2008; Le et al. 2009; Moretti &
Pizzi 2009; Moretti et al. 2009), some of
them even showed 90% sensitivity and
84% speciﬁcity of the ONSD method in
patients with intracranial hypertension
(Bauerle & Nedelmann 2011). However,
in this study, the sample size was very
small (only 10 patients). Others authors
found poor reliability of this method
(Strumwasser et al. 2011). Analysing
glaucoma patients, Jaggi et al. found
that NTG patients had increased
ONSD, obtained by computer tomog-
raphy, similar to those of patients with
increased ICP (Jaggi et al. 2012). How-
ever, Pinto et al. found no statistically
signiﬁcant diﬀerences in ONSD,
obtained by ultrasonography, between
POAG, NTG and healthy controls
(Pinto et al. 2012). Furthermore, Wang
et al. (2012) found decreased optic
nerve SAS width measured by magnetic
resonance imaging with fat-suppressed
fast recovery fast spin echo T2-weighted
sequence in NTG patients, compared
with HTG patients and healthy con-
trols. ONSD is a promising tool for
estimation of ICP elevation (Geeraerts
et al. 2007; Kimberly et al. 2008; Du-
bourg et al. 2011), but not for measure-
ment of normal or decreased ICP.
Controversial data exist in correla-
tion between IOP and ICP (Li et al.
2012). Recent studies suggested a strong
correlationbetween ICPand IOP (Lash-
utka et al. 2004; Sajjadi et al. 2006;
Spentzas et al. 2010), while others did
not ﬁnd (Czarnik et al. 2007; Han et al.
2008; Kirk et al. 2011). Li et al. (2012)
also revealed a signiﬁcant correlation
between CSF pressure and IOP in 130
neurological patients; however, using
IOP as a measurement to predict ICP,
the accuracy rate was found to be
65.4%. In prospective study, Ren and
colleagues found that in normal subjects
CSF pressure is related to the systemic
arterial BP and the IOP (Ren et al.
2010). According to several population-
based studies, IOP is also related to the
systemic arterial BP so that the pressures
in all three ﬂuid ﬁlled compartments are
related to each other (Mitchell et al.
2005; Xu et al. 2007). Salman suggests
that the CSF surrounding the optic
nerve sheath transmits elevations of
ICP through the eyeball, raising the
IOP (Salman 1997). Other potential
mechanisms suggest that the rise in the
ophthalmic venous pressure could be
transmitted directly to the ocular ﬂuid
raising IOP (Hartmann 1998) or
increased venous pressure in the cavern-
ous sinus is transmitted to episcleral
veins by the superior ophthalmic vein
and causes the rise in IOP (Lashutka
et al. 2004).
Xie et al. estimated mathematical
ICP formula based on three parameters
of diastolic BP, age and bodymass index
(ICP = 0.44 9 body mass index (kg/
m2) + 0.16 9 diastolic BP (mmHg) –
0.18 9 age (years) – 1.91). In their
study, measured ICP via lumbar punc-
ture (12.6 (4.8) mmHg) did not diﬀer
signiﬁcantly from the calculated ICP
(13.3 (3.2) mmHg). The Bland–Altman
analysis revealed that 40 of 42 measure-
ments were within the 95% limits of
agreement (Xie et al. 2013). Withal,
formula was developed in a pilot study,
which included a relatively small num-
ber of neurological patients. To estimate
its validity, researchers applied the
mathematical ICP formula to data from
participants in the Beijing Eye Study
and The Central India Eye and Medical
Study (Jonas et al. 2013, 2014a,b). They
found that ICP was signiﬁcantly lower
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and TPG was signiﬁcantly higher in
glaucoma patients, compared with
healthy subjects (p < 0.05). Addition-
ally, they found that calculated TPG
versus IOP showed a better association
with presence of open-angle glaucoma
and amount of glaucomatous optic
neuropathy.
Overall, all these mentioned appro-
aches are based on correlation between
some measured parameters of an ana-
tomic structure with ICP. Unfortu-
nately, correlation-based approaches
are not able to measure absolute ICP
accurately enough for clinical treatment
planning. To express such a correlation-
based ICPmeasurement in absolute ICP
units (mmHg or mmH2O), a patient-
speciﬁc calibration procedure is
required. Thus, there is a need for a
non-invasive absolute ICP measure-
ment device with an accuracy similar to
that of the invasive ‘gold standard’ ICP
metres (Taylor 1997). Seeking to mea-
sure absolute ICP value, researchers
created non-invasive ultrasound-based
measurement – a two-depth transcranial
Doppler (TCD) device – which uses an
ophthalmic artery as a natural pressure
sensor. Accuracy and precision of this
device have been previously investigated
and shown to be clinically useful
(Ragauskas et al. 2005, 2012).
Future Directions – Non-
Invasive Absolute ICP
Measurement
Non-invasive two-depth TCD device
(Vittamed 205, Kaunas, Lithuania) was
developed in the Health Telematics
Science Centre of Kaunas University
of Technology in Lithuania. This tech-
nology is based on simultaneous mea-
surements of blood ﬂow velocities in
the intracranial and extracranial seg-
ments of the ophthalmic artery (OA).
The principle is based on the idea of
non-invasive arterial blood pressure
(ABP) measurement, where externally
applied pressure to a segment of artery
is used to ﬁnd a balance point when the
external pressure is equal to the arterial
pressure measure of interest. Blood
ﬂow parameters in both OA segments
are monitored at the same time, and
two-depth TCD device is used as an
accurate indicator of the pressure bal-
ance point Pe=ICP, where Pe is an
external pressure applied to the non-
compressible tissues of the orbit sur-
rounding an extracranial segment of
the OA. Pressure balance point is
reached when measured blood ﬂow
velocity pulsations in both segments
of the OA are approximately equal.
The absolute ICP measurement value is
expressed in mmHg.
A head frame with ultrasound trans-
ducer for placement over the closed
eyelid is positioned on a patients head.
An external pressure Pe produced by a
small inﬂatable ring cuﬀ placed over
the tissues surrounding the eyeball is
automatically increased gradually from
0 to 20–28 mmHg by 4 or 2 mmHg
pressure steps. This amount of pressure
applied to the external orbital tissue is
equivalent to the underwater pressure
of a person diving at a depth of 38 cm.
The duration of the measurement pro-
cedure is up to 10 min. The structure of
non-invasive two-depth TCD device
components is shown in Fig. 1.
Study with 62 neurological patients
showed that non-invasive two-depth
TCD device is precise (standard devia-
tion = 2.19 mmHg) and accurate (mean
systemic error = 0.12 mmHg) com-
pared with gold standard CSF pressure
measured via lumbar puncture. Mean
ICP measured with non-invasive two-
depth TCD device was 12.76 (3.23)
mmHg (range 4.04–23.71), via lumbar
puncture 13.18 (2.99) mmHg (range
4.41–24.26) (Ragauskas et al. 2012).
Diagnostic reliability of non-inva-
sive two-depth TCD device has also
been compared to ﬁndings of increased
ICP on ONSD ultrasonography in
neurological patients. In this study, all
non-invasive ICP measurements were
compared with invasive CSF pressure
measurements obtained via lumbar
puncture. Study showed that two-
depth TCD device has better reliability
and relationship with CSF pressure
than ONSD method (Figs 2 and 3)
(Ragauskas et al. 2014). To estimate its
validity in glaucoma patients, research-
ers have made a pilot study and found
that TPG was higher in glaucoma
patients compared with healthy con-
trols (p < 0.001). Additionally, reduc-
tion of neuroretinal rim area was
related to higher TPG in NTG patients
(Siaudvytyte et al. 2014).
An interesting point of this method-
ology is that the systemic error of this
ICP measurement is close to zero, and
obtained results are very close to the
Association for the Advancement of
Medical Instrumentation requirements
for invasive ICP measurements (Brain
Trauma Foundation et al. 2007).
Therefore, method is suitable for 96%
or more of patients with normal OA
anatomy, which is normal if OA is a
branch of internal carotid artery and it
has an intracranial segment com-
pressed by ICP. However, the method
depends on the pathway from the
intracranial to the orbital portion of
the SAS of the optic nerve. What
happens if that pathway in the optic
Fig. 1. Non-invasive two-depth TCD device for absolute ICP measurements. The ultrasound
transducer of the Doppler subsystem is surrounded by an externally applied pressure chamber
with a controlled external pressure (Pe) source and measurement. (Reprinted with permission from
Ragauskas et al. 2012).
12
Acta Ophthalmologica 2015
nerve canal or at the inner aperture of
the optic nerve canal is blocked (for
example, by a suprasellar meningioma,
by circular adhesions as a sequel of a
tuberculous meningitis or in patients
with an intracanalicular ophthalmic
artery aneurysm).
Moreover, it still remains unclear
whether the lumbar CSF pressure is
directly related to theCSF in optic nerve
SAS. There are communicates between
CSF in the optic nerve SAS and CSF in
the brain at the site of the chiasmatic
cistern. The CSF dynamics of the re-
trolaminar space probably have unique
properties as there are numerous septae
present that could limit free ﬂow of CSF
(Jaggi et al. 2007). Moreover, the dura
of optic nerve sheath contains atypical
meningeal tissue with lymphoid charac-
teristics (Killer et al. 1999, 2008). Killer
et al. (2012) found reduced CSF
exchange between the basal cisterns
and the SAS surrounding theoptic nerve
in NTG patients, but not in control
subjects. Lower ICP in NTG could
explain the reduced density of the con-
trast-loaded CSF in the SAS of the optic
nerves.Nevertheless, experimental stud-
ies showed that CSF pressure in optic
nerve SAS is identical toCSFpressure at
the same vertical level (Hedges & Zaren
1973; Rios-Montenegro et al. 1973).
However, these studies were made with
cats, whose vasculature of the distal
segment of the optic nerve is dissimilar
to that of the primates, and only few
monkeys. Later Morgan et al. (1995)
revealed that CSF pressure in canine
optic nerve SAS and in the lateral
ventricle at the level of eye is identical,
demonstrating hydrostatic continuity of
the CSF along the canine optic nerve
sheath. In recent study, Lenfeldt et al.
(2007) found that CSF pressure mea-
sured by lumbar puncture accurately
represents ICP in the lateral decubitus
position. Magnaes et al. showed that
CSF pressure at eye level falls by an
average of 14 mmHg as a subject
changes its position from the left lateral
decubitus posture to the sitting or stand-
ing posture (Magnaes 1976). Further-
more, studies have shown that the
retrolaminar tissue pressure is about
4 mmHg when CSF pressure is
0 mmHg (Morgan et al. 1998).
Conclusion
In conclusion, CSF pressure as trans-
laminar counter pressure against IOP
seems to be of major importance in
glaucoma, and future investigations
are needed to elucidate the involve-
ment of CSF pressure and its ﬂuctua-
tions in the development, progression
and management of glaucoma. Up to
the present, time research in glaucoma
was limited due to invasive ICP mea-
surement methods. The role of the
two-depth transcranial Doppler based
non-invasive technology for measuring
absolute ICP in glaucoma patients
would be innovative and may provide
an important aspect currently missing
information in glaucoma pathology
assessment and even change our whole
understanding about glaucoma.
Importantly, to date, this non-invasive
absolute ICP measurement method is
the only available method that does
not need an individual patient-speciﬁc
calibration.
Fig. 2. Relationship between invasive CSF pressure via lumbar puncture and non-invasive ONSD
measurement. Linear regression analysis did not showed relationship between ONSD and CSF
pressure. (Reprinted with permission from Ragauskas et al. 2014).
Fig. 3. Relationship between invasive CSF pressure via lumbar puncture and non-invasive
absolute ICP measurement. Linear regression analysis showed linear relationship between CSF
pressure and non-invasive absolute ICP measured with two-depth TCD device. (Reprinted with
permission from Ragauskas et al. 2014).
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